Write
Up
Cafe
Log in
Join free
pharma12
@pharma12
Joined Sep 2022
0
Followers
14
Writeups
0
Following
Follow
Activities
Writeups
Short Posts
Blogs
Followers
0
Following
0
Popular WriteUps
View all →
Imatinib price
0
0
0
0
Mekinist
0
0
0
0
pirfenidone tablet
0
0
0
0
Recent Activity
pharma12
posted a new writeup in
Health
Oct 12, 2022
Health
inbec tablet
pharma12
·
1 min read
Read More →
0
0
0
Share
pharma12
posted a new writeup in
Health
Oct 11, 2022
Health
imfinzi 500mg price
pharma12
·
1 min read
Read More →
0
0
0
Share
pharma12
posted a new writeup in
Health
Oct 11, 2022
Health
Mekinist
pharma12
·
1 min read
Read More →
0
0
0
Share
pharma12
posted a new writeup in
Health
Oct 10, 2022
Health
Abacavir Lamivudine price
pharma12
·
1 min read
Read More →
0
0
0
Share
pharma12
posted a new writeup in
Health
Oct 8, 2022
Health
pirfenidone tablet
pharma12
·
1 min read
Read More →
0
0
0
Share
pharma12
posted a new writeup in
Health
Oct 8, 2022
Health
abiraterone tablet
pharma12
·
1 min read
Read More →
0
0
0
Share
pharma12
posted a new writeup in
Health
Oct 7, 2022
Health
bortezomib injection
pharma12
·
1 min read
Read More →
0
0
0
Share
pharma12
posted a new writeup in
Health
Oct 7, 2022
Health
plerixafor injection
pharma12
·
1 min read
Read More →
0
0
0
Share
pharma12
posted a new writeup in
Health
Oct 6, 2022
Health
lenvima tablet
pharma12
·
1 min read
Read More →
0
0
0
Share
pharma12
posted a new writeup in
Health
Oct 4, 2022
Health
Lenalidomide 10 mg
pharma12
·
1 min read
Read More →
0
0
0
Share
pharma12
posted a new writeup in
Health
Oct 3, 2022
Health
imfinzi
pharma12
·
1 min read
Read More →
0
0
0
Share
pharma12
posted a new writeup in
Health
Oct 1, 2022
Health
Imatinib price
pharma12
·
1 min read
Read More →
0
0
0
Share
pharma12
posted a new writeup in
Health
Sep 30, 2022
Health
Paclitaxel price
pharma12
·
1 min read
Read More →
0
0
0
Share
pharma12
posted a new writeup in
Health
Sep 30, 2022
Health
Bevacizumab price
pharma12
·
1 min read
Read More →
0
0
0
Share
📌 Pin to profile
📌 Unpin
Report pharma12
×
Your Name
*
Your Email
*
Category
Spam
Abuse
Harassment
Hate Speech
Other
Remarks
(optional)